HER2-driven mammary tumorigenesis enhances bioenergetics despite reductions in mitochondrial content

Sara M Frangos1, Henver S Brunetta1, Dongdong Wang2,3

  • 1Department of Human Health Sciences, University of Guelph, Guelph, Canada.

Elife
|May 6, 2026
PubMed

Insights

Mitochondria are key in cancer, but tumor metabolism varies. This study found higher mitochondrial respiration in HER2-positive breast tumors than expected, suggesting HER2 signaling drives this bioenergetic shift.

Area of Science:

  • Oncology
  • Mitochondrial Biology
  • Cancer Metabolism

Background:

  • Mitochondria are crucial in tumorigenesis, but tumor metabolism differs across cancer types.
  • Previous attempts to target tumor respiration via oxidative phosphorylation inhibitors have failed.
  • Understanding mitochondrial bioenergetics in diverse tumors is critical.

Purpose of the Study:

  • To comprehensively assess the metabolic phenotype of mitochondria in murine HER2-driven mammary cancer.
  • To investigate the relationship between mitochondrial content and respiratory capacity in tumors.
  • To explore the role of HER2 signaling in regulating mitochondrial bioenergetics.

Main Methods:

  • Transcriptomic and proteomic profiling of murine HER2-driven mammary tumors and benign mammary tissue.
  • Measurement of mitochondrial respiration using various normalization methods.
  • Assessment of the effect of lapatinib (EGFR/HER2 inhibitor) on mitochondrial respiration in tumor cells.

Main Results:

  • Tumors showed downregulation of mitochondrial genes and proteins, including oxidative phosphorylation (OXPHOS) subunits.
  • Despite reduced mitochondrial proteins, tumor mitochondrial respiration was significantly higher than in benign tissue.
  • This increased respiration was not due to OXPHOS uncoupling and was attenuated by lapatinib treatment.

Conclusions:

  • The correlation between mitochondrial content and respiratory capacity may not hold true for all tumor types.
  • HER2 signaling appears to intrinsically regulate mitochondrial bioenergetics, enhancing respiration.
  • HER2-linked activation of mitochondrial respiration supports tumorigenesis in this model.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K